Develops precision epigenetic medicines targeting adipose biology and cardiometabolic disease using AI-driven epigenetic profiling and engineering.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.